Treatment.com International Inc
CNSX:TRUE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (10.1), the stock would be worth CA$-0.58 (165% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -15.7 | CA$0.89 |
0%
|
| Industry Average | 10.1 | CA$-0.58 |
-165%
|
| Country Average | 16.7 | CA$-0.95 |
-207%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
T
|
Treatment.com International Inc
CNSX:TRUE
|
71.7m CAD | -15.7 | -9.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
303.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 45 425.5 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.5B ZAR | 18.1 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68B USD | -45 946.1 | 38 417.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
61.5B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.4B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
38.1B USD | 42.3 | -3 495.5 | |
| US |
|
Coupang Inc
F:788
|
31.7B EUR | 17.9 | 175.5 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.4B USD | 39.5 | 56.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
Treatment.com International Inc
Glance View
Treatment.com International, Inc. engages in the research and development, business development of consumer health services delivered by mobile app technology. The company is headquartered in Bloomington, Minnesota. The company went IPO on 2021-04-19. The firm has developed an artificial intelligence (AI) platform to help patients and caregivers around the globe to make better health decisions. The firm offers treatment digital health application, which is driven by an intelligent digital health assistant that allows people to take control of their health. The company is a revolutionary symptom assessment tool. Its treatment mobile app provides specialist-level symptom checking, integrated medication logistics, and personalized curated assessments based on the individual user. The Company’s solutions include treatment clinical and treatment commercial. Its treatment clinical solutions include global library of medicine (GLM), treatment intelligent digital assistant, treatment triage, treatment dermatology, treatment ophthalmology and treatment medical education. Its treatment commercial solutions include rewards distribution, membership, and social network.
